Analysts Set Expectations for Crescent Capital BDC, Inc.’s FY2022 Earnings (NASDAQ:CCAP)

Crescent Capital BDC, Inc. (NASDAQ:CCAPGet Rating) – Analysts at Oppenheimer dropped their FY2022 earnings per share (EPS) estimates for Crescent Capital BDC in a report issued on Tuesday, May 10th. Oppenheimer analyst M. Penn now expects that the company will post earnings per share of $1.62 for the year, down from their previous forecast of $1.64.

Other equities analysts also recently issued research reports about the stock. Bank of America initiated coverage on shares of Crescent Capital BDC in a research note on Monday, January 31st. They issued a “buy” rating and a $19.50 target price for the company. Zacks Investment Research cut shares of Crescent Capital BDC from a “hold” rating to a “sell” rating in a research note on Tuesday, April 26th. Finally, Wells Fargo & Company reduced their price objective on shares of Crescent Capital BDC from $19.50 to $18.50 and set an “overweight” rating for the company in a research note on Monday, April 25th. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company. Based on data from, Crescent Capital BDC presently has a consensus rating of “Hold” and an average target price of $19.70.

CCAP opened at $17.02 on Thursday. The company has a market capitalization of $525.70 million, a price-to-earnings ratio of 5.79, a PEG ratio of 0.88 and a beta of 0.88. The company has a quick ratio of 1.37, a current ratio of 1.37 and a debt-to-equity ratio of 0.97. The firm has a 50-day moving average price of $17.72 and a 200-day moving average price of $18.20. Crescent Capital BDC has a twelve month low of $16.58 and a twelve month high of $21.48.

Crescent Capital BDC (NASDAQ:CCAPGet Rating) last announced its quarterly earnings data on Wednesday, February 23rd. The company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.41 by $0.01. The business had revenue of $24.14 million for the quarter, compared to analyst estimates of $24.24 million. Crescent Capital BDC had a net margin of 88.98% and a return on equity of 8.03%.

Large investors have recently added to or reduced their stakes in the company. Captrust Financial Advisors purchased a new stake in shares of Crescent Capital BDC in the 3rd quarter worth about $103,000. JPMorgan Chase & Co. purchased a new stake in Crescent Capital BDC during the 1st quarter valued at about $185,000. LPL Financial LLC purchased a new stake in Crescent Capital BDC during the 4th quarter valued at about $190,000. Comerica Bank purchased a new stake in Crescent Capital BDC during the 3rd quarter valued at about $215,000. Finally, Eagle Global Advisors LLC purchased a new stake in Crescent Capital BDC during the 4th quarter valued at about $222,000. 54.76% of the stock is currently owned by hedge funds and other institutional investors.

In other Crescent Capital BDC news, Director Raymond Barrios acquired 2,875 shares of the stock in a transaction dated Tuesday, March 1st. The stock was purchased at an average cost of $17.43 per share, for a total transaction of $50,111.25. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 1.08% of the company’s stock.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 15th. Stockholders of record on Thursday, June 30th will be issued a $0.41 dividend. The ex-dividend date of this dividend is Wednesday, June 29th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 9.64%. Crescent Capital BDC’s payout ratio is 55.78%.

About Crescent Capital BDC (Get Rating)

Crescent Capital BDC, Inc is a business development company. The fund focuses on originating and investing in the debt of middle market companies. It typically focuses on companies based in United States.

Read More

Earnings History and Estimates for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with's FREE daily email newsletter.